about
Evidence of increased circulation of Bordetella pertussis in the Italian adult population from seroprevalence data (2012-2013).Severe pertussis infection in infants less than 6 months of age: Clinical manifestations and molecular characterization.Live attenuated B. pertussis BPZE1 rescues the immune functions of Respiratory Syncytial virus infected human dendritic cells by promoting Th1/Th17 responsesT-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections.The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.CD38 ligation in peripheral blood mononuclear cells of myeloma patients induces release of protumorigenic IL-6 and impaired secretion of IFNγ cytokines and proliferation.Chlamydia pneumoniae modulates human monocyte-derived dendritic cells functions driving the induction of a Type 1/Type 17 inflammatory response.60-kDa heat shock protein of Chlamydia pneumoniae promotes a T helper type 1 immune response through IL-12/IL-23 production in monocyte-derived dendritic cells.The virulence factors of Bordetella pertussis: talented modulators of host immune response.T-cell immune responses to Bordetella pertussis infection and vaccination.Does Breastfeeding Protect Young Infants From Pertussis? Case-control Study and Immunologic Evaluation.Pertussis in infants and the resurgence of a vaccine preventable disease: what to do? Commentary.Parents as source of pertussis transmission in hospitalized young infants.Hematopoietic support and cytokine expression of murine-stable hepatocyte cell lines (MMH).Unconventional, adenosine-producing suppressor T cells induced by dendritic cells exposed to BPZE1 pertussis vaccine.Protection against Pertussis in Humans Correlates to Elevated Serum Antibodies and Memory B CellsInvasion of Dendritic Cells, Macrophages and Neutrophils by the Bordetella Adenylate Cyclase Toxin: A Subversive Move to Fool Host Immunity.Bordetella pertussis-infected human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization and interleukin-23 expression.Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways.Lipooligosaccharide from Bordetella pertussis induces mature human monocyte-derived dendritic cells and drives a Th2 biased response.CD38 modulates respiratory syncytial virus-driven pro-inflammatory processes in human monocyte-derived dendritic cells.Diagnostic performance of commercial serological assays measuring Bordetella pertussis IgG antibodies.Analysis of the immune response in infants hospitalized with viral bronchiolitis shows different Th1/Th2 profiles associated with Respiratory Syncytial Virus and Human Rhinovirus.Native and Genetically Inactivated Pertussis Toxins Induce Human Dendritic Cell Maturation and Synergize with Lipopolysaccharide in Promoting T Helper Type 1 ResponsesIdentity and ranking of colonic mesenchymal stromal cellsImmunomodulatory activities of surface-layer proteins obtained from epidemic and hypervirulent Clostridium difficile strainsSurface layer proteins from Clostridium difficile induce inflammatory and regulatory cytokines in human monocytes and dendritic cellsPertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis VaccinesMulticentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring
P50
Q31076592-9468D054-A72A-4B0E-91A9-874FEE0F2979Q33724387-529030BE-74F5-4F0C-AE2C-954CD138BFD1Q33812212-7F4F11B0-FF73-459A-826D-57CA23B76E33Q35140321-E8EDEDC8-6471-48C3-BC94-8EC5BF95A250Q36452353-E0D7D49C-A41C-4615-A95E-D53B1C9781A7Q36892616-64B93A85-86E5-40BB-877F-0B7EF5DF5C16Q37483026-7711F11A-E152-49ED-8233-C09CF7BA6180Q37847636-FECA949A-B318-4930-97F2-A4C0F0451746Q37862985-5D9FF4F9-725B-4801-B14C-5E81DC87B064Q38129761-E647C29E-512E-4E76-8785-3310A257DDB1Q38560699-3BDABB83-C242-4AB8-9A34-9B72170283DFQ39167941-B27A5040-7270-4D73-850E-959D7037D76AQ40159155-CF5FF9EB-2687-401E-8636-8FDF1FA06AF3Q40544517-5246C946-46B8-44AE-AE96-6C3A02572E8DQ40992631-E4555F51-C377-4C03-934A-8D2108342816Q41151708-40AF5949-0D4B-4D4A-9C35-41896CA2DC56Q41665234-6DA320B8-A4FF-48FA-A318-4F586BB295A8Q41995672-41327C5E-B8E9-49CF-8900-F1E9735CE569Q42125528-99818A65-A7CF-41D5-A929-008E20F817CFQ42936693-102570E4-C202-4624-9619-1C7FD2BC33D5Q44555087-5ACA8A23-3E2E-4FB6-9986-FEAA615BC7BCQ45324208-7B9062CE-BEDE-4567-AF60-269EB1A8DF63Q49993756-514EEFAF-CAD4-4178-BD70-CDBFC6B6F55AQ54225240-AC2A113D-E250-4952-8466-C52FB0DB977EQ62736207-F90D2237-7A3A-483C-81C5-91648D069207Q63282794-B530FA55-5005-493C-86E2-376C14931B53Q63762220-754A05D5-5094-48D1-B80E-CF1901123F69Q80173524-B37BB8DF-A212-44B4-B2E4-FCCBFFB6611DQ92106718-384CB7BE-341B-41CB-B2DF-934BD28801B3Q93167058-BB84CD5A-7FED-4507-BA2B-C85A84920F4D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giorgio Fedele
@ast
Giorgio Fedele
@en
Giorgio Fedele
@es
Giorgio Fedele
@nl
type
label
Giorgio Fedele
@ast
Giorgio Fedele
@en
Giorgio Fedele
@es
Giorgio Fedele
@nl
prefLabel
Giorgio Fedele
@ast
Giorgio Fedele
@en
Giorgio Fedele
@es
Giorgio Fedele
@nl
P106
P1153
57190210446
7003460880
P31
P496
0000-0003-0017-6711